RxDoctor Payments Data

Sharla Carroll, PA

Physician Assistant · Eastland, TXNPI 1689739278

Payments from drug & device makers

$3,628in general payments, 2019–2025

Across 214 payments — averaging $16.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$858
  • Lilly USA, LLC$412
  • AbbVie$366
  • Astellas Pharma US Inc$343
  • Merck$160
  • Novo Nordisk$154
  • plus $1K from 25 others

What the payments were for

  • Food & beverage$3,628100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,628 in reported general payments places this provider in the 85th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$42,755
Medicare patients
187
Services billed
1,118

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide57$59,199
EliquisApixaban68$47,836
TrulicityDulaglutide46$46,082
LinzessLinaclotide32$21,076
JardianceEmpagliflozin30$18,722
XareltoRivaroxaban18$17,270
Breztri AerosphereBudesonide/Glycopyr/Formoterol24$14,280
TradjentaLinagliptin25$11,711
MyrbetriqMirabegron22$11,319
JanumetSitagliptin Phos/Metformin Hcl15$9,222
Lantus SolostarInsulin Glargine,hum.Rec.Anlog48$7,021
JanuviaSitagliptin Phosphate12$6,650
Dexlansoprazole DrDexlansoprazole23$4,415
ActonelRisedronate Sodium11$3,859
Levothyroxine Sodium415$3,255

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$412$105,281103 claims
PfizerEliquis$19$47,83668 claims
AbbVieLinzess, Synthroid$366$22,05965 claims
Johnson & JohnsonXarelto$13$17,27018 claims
MerckJanumet, Januvia$160$15,87327 claims
AstraZenecaBreztri Aerosphere$858$14,28024 claims
Astellas Pharma US IncMyrbetriq$343$11,31922 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Eastland

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →